OTC · KAYS
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 3:53 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · KAYS
1M range · 0 trading sessions · Daily adjusted prices
KAYS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning KAYS.
Company
Market Activity
Research & News
KAYS research
Company profile and research snapshot.
KAYA HOLDINGS INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Nov 22, 2025
Valuation and Earnings This table compares Pigeon and Kaya"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pigeon $688.99 million 1.94 $55.26 million $0.13 21.54 Kaya $10,000.00 176.67 -$2.08 million ($0.20) -0.21 Pigeon has higher revenue and earnings than Kaya. Kaya is trading at
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning KAYS.
No results
No recent SID articles mention KAYS.
